The evolution of long-term treatment for the patient with chronic renal failure over the last 15 years has resulted in their present management by two major methods: chronic haemodialysis or renal transplantation of cadaveric or living related donor organs. These methods used singly or together have significantly ameliorated the prognosis for the renal patient though not without deleterious sequelae.
The increased risks of serum hepatitis,'-3 tuberculosis,4 and other infections are shared equally; however, for other reasons (vide infra) there is a universal preference for transplantation.
In the past, the search for donors to fulfil the overwhelming demand for organs resulted in the use of carcinomatous cadavers and the emergence of a unique complication. This, the inadvertent transplantation of malignancy, was first reported by McPhaul and McKintosh;5 they described in 1965 the transfer of a donor's squamous carcinoma of bronchus to a young woman recipient who later died with hepatic mnetastases. About the same time, Couch et al. 6 published'guidelines' concerning the use of such cadaver organs. Despite these, and an increasingly rigorous medical selection of possible donors, sporadic cases of transplanted malignancy continue. We report a case of this uncommon phenomenon to revive clinical awareness and to stimulate even greater vigilance.
Accepted for publication 27 August 1980 The donor HISTORY A 36-year-old woman was admitted unconscious and areflexic with absent eye movements and fixed dilated pupils but no neck stiffness or papilloedema. Her blood pressure, pulse, and cerebrospinal fluid were all normal. A recent admission after an 'overdose' of analgesics, resulting from severe headaches, led to the diagnosis of a second 'overdose', but investigations revealed no paracetamol, salicylate, or barbiturates in the blood.
She remained unchanged, requiring ventilation for three days. Brain death7 was then established and her kidneys were offered for transplantation.
Both organs were removed six days after admission (Friday), offered to, and accepted through the UK Transplant Service. (Fig. 1) . There was vascular invasion, and one section revealed a large embolus of neoplastic cells in a major pulmonary vessel (Fig. 2) severe atheroma of the left coronary artery, and total occlusion of the right coronary artery by fresh thrombus. Most of the aorta and its pelvic branches were replaced by complicated atheromatous plaques; the right internal iliac artery was indeed totally occluded. The liver exhibited the 'nutmeg' appearance of heart failure, and the patient's own kidneys were sclerotic (75 g each).
All the transplanted kidney's anastamoses were intact and patent, and externally it was unremarkable. Bisection of the kidney, however, revealed a vaguely demarcated, pale, focally necrotic tumour (Fig. 3) . There was no macroscopic evidence of local spread or metastasis to the other organs.
These findings were consistent with the cardiorespiratory death proposed on clinical grounds. We believe that the transplanted tumour did not alter the prognosis or significantly contribute to the acute terminal events in this case. 
Histology
The transplant contained an invasive, poorly differentiated adenocarcinoma (Fig. 4) Primary malignancies of many organs have been accidentally transplanted (for an earlier review, see Wilson15), including the kidney itself. Fox16 has even described the discovery of a primary renal tumour during laparotomy of a living related donor.
The growth and dissemination of transplanted malignancy is comprehensibly explained by the 'fertile field' provided by the recipient and is inextricably linked with the necessity for immunosuppression and close donor tissue type matching. These measures, designed to enhance graft survival, are equally beneficial to the 'foreign' tumour.
The recipient's inability to reject foreign tissue is accompanied by an increased incidence of de novo primary malignancies, a phenomenon described in both renal and cardiac transplantation.'7 The types of such primary lesions are described in standard medical texts (see, for example, Meadows'8 and Williams '9 In retrospect the recipient's complaint of a slight groin ache may have been referable to the tumour; however, it was of less than 72 hours' duration and was unaccompanied by other symptoms or signs, for example, haematuria, urinary tract infection or a palpable mass. The preterminally high serum urea (44 mmol/l) may equally have been attributable to the tumour, though it would then be difficult to explain its resolution (to 17 mmol/l) on increasing the immunosuppressive therapy, a situation, in theory, resulting in accelerated tumour growth and consequent elevation of urea. More probably, the preterminal uraemia was of multifactorial origin, metabolic imbalance, cardiac failure, and chronic rejection also contributing. Even had these two equivocal features been investigated and ascribed to a transplanted tumour, probably little could have been done to avert the eventual outcome for this particular patient.
Until more sophisticated drugs and techniques are available specifically to protect transplanted organs, primary de novo malignancy will continue as a complication for the recipient. Comparatively, the accidental transference of malignancy, though it may not be entirely abolished, may possibly be reduced in several ways.
First, the use of donors known to have had a malignancy at any time, even 'cured' long-term survivors, is to be strongly deprecated. Lastly, we hope that the awareness of transferred malignancy among the non-specialist press and patients themselves (see Neustatter25) will stimulate clinicians to be more discerning in their selection of donors, and appreciative of minor complaints from transplant recipients referable to neoplasia.
In summary, it seems that primary malignancies of transplant recipients are an unfortunate complication of their requisite therapy. Comparatively, the transferral of donor malignancy appears a relatively facile problem to overcome. We can foresee, however, that all procedures in which large tissue masses are transplanted from one person to another will inevitably result in the occasional inadvertent transfer of a microscopic nidus of malignant cells, no matter how rigorous the donor selection. 
